脂肪酸模拟片段作为肝脏受体同类-1调节器
Alisa Lang1, Tanja Stiller2, Niklas Ildefeld1
1Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, 60438 Frankfurt, Germany.
ACS pharmacology & translational science
|March 20, 2025
概括
研究人员发现了新的脂肪酸模仿剂,可调节肝受体同源-1 (LRH-1),这是代谢和炎症性疾病的关键因素. 这些发现为开发用于治疗应用的新型LRH-1激动剂提供了潜力.
科学领域:
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
- 药物发现 药物发现
背景情况:
- 肝受体同源-1 (LRH-1) 是一种转录因子,对调节参与胆固醇和葡萄糖代谢,炎症和内质网膜应激的基因至关重要.
- LRH-1主要在肝脏,肠道和胰腺表达,使其成为代谢疾病和炎症状况的重要点.
- 现有的LRH-1调节剂很少,尽管它在代谢障碍,炎症甚至避孕方面的治疗潜力很大.
研究的目的:
- 探索脂肪酸模仿剂作为LRH-1的潜在调节剂,利用其已知的脂结合特性.
- 通过聚焦片段查,发现LRH-1的新型联体化学型.
- 为了确定有希望的化合物用于LRH-1激动剂的发展.
主要方法:
- 针对性的断片选被用于识别潜在的LRH-1调节器.
- 在已识别的碎片上进行了结构-活性关系 (SAR) 阐明.
- 进行了对等活动验证和目标参与研究,以确认调节效应.
主要成果:
- 通过碎片查发现了针对LRH-1的新配体化学型.
- 预先的SAR研究为确定化合物的结构-活性关系提供了初步见解.
- 为进一步开发LRH-1激动剂,突出展示了两个显示有前途的活动的碎片样线索.
结论:
- 脂肪酸模仿剂是发现LRH-1调节器的可行策略.
- 已识别的碎片状线索需要进一步调查,以开发新型LRH-1激动剂.
- 这项研究为通过LRH-1调节准代谢和炎症疾病的治疗干预开辟了新的途径.
相关概念视频
01:31Transducer Mechanism: Nuclear Receptors
1.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.2K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
492
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
492
01:06Lipid Digestion
90.0K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
90.0K
01:28Overview of Fatty Acid Metabolism
30.1K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.1K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
23
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
23